Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status

The treatment of patients with human epidermal growth factor receptor 2 (HER2)-negative gastric cancer is a major challenge. Immunotherapy using immune checkpoint inhibitors is a rapidly growing field. In a number of malignancy types it has been demonstrated that patients with mismatch repair defici...

Descripción completa

Detalles Bibliográficos
Autores principales: Valentini, Anna Maria, Di Pinto, Federica, Coletta, Sergio, Guerra, Vito, Armentano, Raffaele, Caruso, Maria Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614673/
https://www.ncbi.nlm.nih.gov/pubmed/31423245
http://dx.doi.org/10.3892/ol.2019.10513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614673/
https://www.ncbi.nlm.nih.gov/pubmed/31423245
http://dx.doi.org/10.3892/ol.2019.10513

Ejemplares similares